Resonetics to Acquire Resolution Medical, Expanding Medical Device Capabilities
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1d ago
0mins
Source: Newsfilter
- Acquisition Agreement: Resonetics has announced the signing of an agreement to acquire Resolution Medical, a leading provider of integrated design and manufacturing solutions for complex medical devices, with the transaction expected to close in 2026, enhancing Resonetics' capabilities in high-growth neuromodulation and structural heart markets.
- Technical Integration Advantage: Resolution Medical brings over 240 employees, including more than 100 engineers, and a strong reputation for high-quality design engineering and new product introduction, which will provide Resonetics with deeper technical capabilities to enhance customer service quality.
- Market Expansion Potential: This acquisition will enable Resonetics to offer more comprehensive solutions in the medical device industry, supporting customers with increasingly complex devices across the full product lifecycle, thereby positioning the company more favorably in a competitive market.
- Independent Operation Phase: Until the transaction closes, Resonetics and Resolution Medical will continue to operate independently, ensuring that customers receive high-quality service and support during the transition while maintaining existing customer relationships.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
Analyst Views on CG
Wall Street analysts forecast CG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CG is 67.91 USD with a low forecast of 53.00 USD and a high forecast of 83.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
7 Buy
4 Hold
1 Sell
Moderate Buy
Current: 60.540
Low
53.00
Averages
67.91
High
83.00
Current: 60.540
Low
53.00
Averages
67.91
High
83.00
About CG
The Carlyle Group Inc. is a global investment company. The Company's segments include Global Private Equity, Global Credit and Carlyle AlpInvest. The Global Private Equity segment advises the Company's buyout, growth, real estate, infrastructure, and natural resources funds. The segment also includes the NGP Carry Funds advised by NGP Energy Capital Management (NGP). The Global Credit segment advises funds and vehicles that pursue investment strategies including insurance solutions, liquid credit, opportunistic credit, direct lending, asset-backed finance, aviation finance, infrastructure credit, cross-platform credit products, and global capital markets. The Carlyle AlpInvest segment advises global private equity programs that pursue secondary purchases and financing of existing portfolios, managed co-investment programs, and primary fund investments. The Carlyle AlpInvest segment helps investors meet their objectives through tailored portfolio construction and investment selection.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Lukoil Sells International Assets to Carlyle Group
- Deal Overview: Lukoil has agreed to sell most of its international assets to Carlyle Group, marking a significant strategic shift for the company, although financial terms remain undisclosed.
- Asset Scope: The transaction excludes Lukoil's assets in Kazakhstan, indicating the company's intent to maintain investment in specific markets, which may influence its business positioning in the region.
- Regulatory Approval: The deal is subject to regulatory approvals, highlighting the necessity for Lukoil to comply with various legal frameworks across global markets, potentially affecting the timeline and outcome of the transaction.
- Negotiations with Buyers: Lukoil is continuing discussions with other potential buyers, demonstrating the company's flexibility in asset disposal and its keen awareness of market opportunities.
Continue Reading
Carlyle Secured Lending Schedules Q4 2025 Earnings Call
- Earnings Announcement Schedule: Carlyle Secured Lending will release its financial results for Q4 and full year 2025 on February 24, 2026, followed by a conference call on February 25 at 11:00 AM ET, enhancing transparency and investor confidence through detailed financial insights.
- Webcast Availability: The conference call will be accessible via a public webcast on the company's website, ensuring that all investors can obtain real-time financial information, thereby improving communication efficiency and reinforcing market trust.
- Company Background: Founded in 2013, Carlyle Secured Lending focuses on providing directly originated financing solutions, particularly senior secured loans to middle-market companies in the U.S., highlighting its expertise and market positioning in the SME financing sector.
- Management Team Strength: The company is externally managed by Carlyle Global Credit Investment Management, an SEC-registered investment adviser with extensive industry experience and robust capital management capabilities, providing solid support for the company's ongoing growth.
Continue Reading